skip to content
Health innovation and value Preview this item
ClosePreview this item
Checking...

Health innovation and value

Author: NICE Citizens Council,; National Institute for Clinical Excellence (Great Britain),
Publisher: London : National Institute for Health and Care Excellence (NICE), 2009.
Series: Citizens Council reports, no. 12.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
The Citizens Council provides NICE with a public perspective on overarching moral and ethical issues that NICE should take into account when producing guidance. Made up of members of the public, broadly representative of the adult UK population, the Council operates through a "citizens' jury" style meeting, to explore and respond to a question set by NICE. At its May 2009 meeting, the Citizens Council was asked to  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: NICE Citizens Council,; National Institute for Clinical Excellence (Great Britain),
OCLC Number: 1021257301
Description: 1 online resource (1 PDF file (35 pages)) : illustrations.
Series Title: Citizens Council reports, no. 12.
Responsibility: NICE Citizens Council.

Abstract:

The Citizens Council provides NICE with a public perspective on overarching moral and ethical issues that NICE should take into account when producing guidance. Made up of members of the public, broadly representative of the adult UK population, the Council operates through a "citizens' jury" style meeting, to explore and respond to a question set by NICE. At its May 2009 meeting, the Citizens Council was asked to provide insight into the public's view of innovation, and to explore which features of innovation should be considered when assessing its value, specifically in the context of health care. The aim was to provide a report to be fed into a study on the value of innovation in health care being carried out on behalf of NICE by Sir Ian Kennedy. The Council was asked: "What makes innovation valuable to you?" From a list of features that might make a healthcare innovation valuable, each member was asked to choose the three they felt were most valuable. The features, with number of votes shown in brackets, were: 1. It increases quality of life (26)2. Other innovations may be developed from it in the future (11)3. A large number of people will benefit from it (10)4. It saves your life (9)5. It increases life expectancy (9)6. It meets a previously unmet need (6)7. It prevents a condition (5)8. It cures a condition (5)9. There are few other treatment options (1)10. It reduces risk to the patient (0)11. It has a one-off cost rather than ongoing costs (0) We were also asked to tackle two other questions. First, if the innovation is more expensive than NICE's current cost per QALY gained threshold and does not demonstrate benefits at the moment but could well do so in the future, what should NICE do? Fifteen of us (a majority of two) responded that we should say "no" for the present, and ask the developers to fund and carry out more research themselves. The remaining 13 of our members also wanted us to say "no" for the present, but preferred that further research be co-funded for the developers on condition that the public would get a return proportionate to any investment. For a clearer insight into these conclusions we were asked more specifically who should bear the costs and risks of research and development. We had five choices: the developer; the NHS; the taxpayer; charities; joint sharing between taxpayer and developer. Seventeen of us felt that the developer of the technology should bear the full cost. The rest, 11 in total, opted for joint sharing between the taxpayer and the developer. We also offered NICE a raft of suggestions (listed in the body of the report) on how it might improve its communication with the public about innovation.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1021257301> # Health innovation and value
    a schema:Book, schema:CreativeWork, schema:MediaObject ;
    library:oclcnum "1021257301" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/enk> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4744339644#Topic/public_opinion> ; # Public Opinion
    schema:about <http://experiment.worldcat.org/entity/work/data/4744339644#Topic/quality_of_health_care> ; # Quality of Health Care
    schema:about <http://experiment.worldcat.org/entity/work/data/4744339644#Place/united_kingdom> ; # United Kingdom.
    schema:about <http://experiment.worldcat.org/entity/work/data/4744339644#Topic/guidelines_as_topic> ; # Guidelines as Topic
    schema:about <http://experiment.worldcat.org/entity/work/data/4744339644#Topic/diffusion_of_innovation> ; # Diffusion of Innovation
    schema:about <http://experiment.worldcat.org/entity/work/data/4744339644#Topic/quality_of_life> ; # Quality of Life
    schema:author <http://experiment.worldcat.org/entity/work/data/4744339644#Organization/nice_citizens_council> ; # NICE Citizens Council,
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/4744339644#Organization/national_institute_for_clinical_excellence_great_britain> ; # National Institute for Clinical Excellence (Great Britain),
    schema:datePublished "2009" ;
    schema:description "The Citizens Council provides NICE with a public perspective on overarching moral and ethical issues that NICE should take into account when producing guidance. Made up of members of the public, broadly representative of the adult UK population, the Council operates through a "citizens' jury" style meeting, to explore and respond to a question set by NICE. At its May 2009 meeting, the Citizens Council was asked to provide insight into the public's view of innovation, and to explore which features of innovation should be considered when assessing its value, specifically in the context of health care. The aim was to provide a report to be fed into a study on the value of innovation in health care being carried out on behalf of NICE by Sir Ian Kennedy. The Council was asked: "What makes innovation valuable to you?" From a list of features that might make a healthcare innovation valuable, each member was asked to choose the three they felt were most valuable. The features, with number of votes shown in brackets, were: 1. It increases quality of life (26)2. Other innovations may be developed from it in the future (11)3. A large number of people will benefit from it (10)4. It saves your life (9)5. It increases life expectancy (9)6. It meets a previously unmet need (6)7. It prevents a condition (5)8. It cures a condition (5)9. There are few other treatment options (1)10. It reduces risk to the patient (0)11. It has a one-off cost rather than ongoing costs (0) We were also asked to tackle two other questions. First, if the innovation is more expensive than NICE's current cost per QALY gained threshold and does not demonstrate benefits at the moment but could well do so in the future, what should NICE do? Fifteen of us (a majority of two) responded that we should say "no" for the present, and ask the developers to fund and carry out more research themselves. The remaining 13 of our members also wanted us to say "no" for the present, but preferred that further research be co-funded for the developers on condition that the public would get a return proportionate to any investment. For a clearer insight into these conclusions we were asked more specifically who should bear the costs and risks of research and development. We had five choices: the developer; the NHS; the taxpayer; charities; joint sharing between taxpayer and developer. Seventeen of us felt that the developer of the technology should bear the full cost. The rest, 11 in total, opted for joint sharing between the taxpayer and the developer. We also offered NICE a raft of suggestions (listed in the body of the report) on how it might improve its communication with the public about innovation."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4744339644> ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/4744339644#Series/citizens_council_reports> ; # Citizens Council reports ;
    schema:name "Health innovation and value"@en ;
    schema:productID "1021257301" ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK401692/> ;
    schema:url <https://www.ncbi.nlm.nih.gov/books/NBK401692> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1021257301> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4744339644#Organization/national_institute_for_clinical_excellence_great_britain> # National Institute for Clinical Excellence (Great Britain),
    a schema:Organization ;
    schema:name "National Institute for Clinical Excellence (Great Britain)," ;
    .

<http://experiment.worldcat.org/entity/work/data/4744339644#Organization/nice_citizens_council> # NICE Citizens Council,
    a schema:Organization ;
    schema:name "NICE Citizens Council," ;
    .

<http://experiment.worldcat.org/entity/work/data/4744339644#Place/united_kingdom> # United Kingdom.
    a schema:Place ;
    schema:name "United Kingdom." ;
    .

<http://experiment.worldcat.org/entity/work/data/4744339644#Series/citizens_council_reports> # Citizens Council reports ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1021257301> ; # Health innovation and value
    schema:name "Citizens Council reports ;" ;
    .

<http://experiment.worldcat.org/entity/work/data/4744339644#Topic/diffusion_of_innovation> # Diffusion of Innovation
    a schema:Intangible ;
    schema:name "Diffusion of Innovation"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4744339644#Topic/guidelines_as_topic> # Guidelines as Topic
    a schema:Intangible ;
    schema:name "Guidelines as Topic"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4744339644#Topic/quality_of_health_care> # Quality of Health Care
    a schema:Intangible ;
    schema:name "Quality of Health Care"@en ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.